Cleared Traditional

K240225 - Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave E8 Peripheral IVL Catheter (FDA 510(k) Clearance)

Mar 2024
Decision
56d
Days
Class 2
Risk

K240225 is an FDA 510(k) clearance for the Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave E8 Peripheral IVL Catheter. This device is classified as a Percutaneous Catheter, Ultrasound (Class II - Special Controls, product code PPN).

Submitted by Shockwave Medical, Inc. (Santa Clara, US). The FDA issued a Cleared decision on March 22, 2024, 56 days after receiving the submission on January 26, 2024.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1250. Intended For Ultrasound Wave Enhanced Balloon Dilatation Of Lesions, Including Calcified Lesions, In The Peripheral Vasculature..

Submission Details

510(k) Number K240225 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 26, 2024
Decision Date March 22, 2024
Days to Decision 56 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code PPN - Percutaneous Catheter, Ultrasound
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1250
Definition Intended For Ultrasound Wave Enhanced Balloon Dilatation Of Lesions, Including Calcified Lesions, In The Peripheral Vasculature.